R&D CBC-XE HEMATOLOGY CONTROL— 510(k) K042094

Substantially Equivalent

R&D Systems, Inc.

FDA 510(k) clearance K042094 for R&D CBC-XE HEMATOLOGY CONTROL, Substantially Equivalent on 2004-09-01. Applicant: R&D Systems, Inc..

Clearance details

Applicant: R&D Systems, Inc.
Product code: Code JPK
Advisory panel: Hematology
Date received: 2004-08-03
Decision date: 2004-09-01
Decision: Substantially Equivalent
Clearance type: Special
Location: Minneapolis, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.